Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial

Clinical Trials

Volumn 8, Issue 2, 2011, Pages 214-223

  Duda, Catherine ^a   Mahon, Irene ^b   Chen, Mei Hsiu ^c   Snyder, Bradley ^c   Barrd, Richard ^d,e   Chiles, Caroline ^f   Falk, Robert ^g   Fishman, Elliot K ^h   Gemmel, David ^d   Goldin, Jonathan G ^a   Brown, Kathleen ^a   Munden, Reginald F ⁱ   Vydareny, Kay ^j   Aberle, Denise R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AMERICAN COLLEGE OF RADIOLOGY   (United States)

^c BROWN UNIVERSITY   (United States)

^d St Elizabeth Health Partners   (United States)

^e Forum Health   (United States)

^f WAKE FOREST BAPTIST HEALTH   (United States)

^g Jewish Heart and Lung Institute   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^j EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL (TOPIC); COST; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FEMALE; HUMAN; MALE; MINORITY GROUP; PRIORITY JOURNAL; RACE DIFFERENCE; SCREENING; SOCIOECONOMICS;

AGED; COSTS AND COST ANALYSIS; EARLY DETECTION OF CANCER; ETHNIC GROUPS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; MINORITY GROUPS; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 79959256577     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774510396742     Document Type: Article

References (11)

1. Mastroianni AC, Faden RR, Federman DD. (eds). NIH Revitalization Act. Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies. Vol. 1 Institute of Medicine (US), Committee on the Ethical and Legal Issues Relating to the Inclusion of Women in Clinical Studies, National Academy Press, Washington, DC, 1994, pp. 233-36.
2. Ford JG, Howerton WM, Bolen S, et al. Evidence report on knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Evidence Report/Technology Assessment No. 05-E019-2, Johns Hopkins University Evidence-Based Practice Center, Baltimore, MD, USA, 2005.
3. Ford JG, Howerton MW, Lai GY, et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 2008; 112: 228-42.
4. Hays J, Hunt JR, Hubbell FA, et al. The WHI recruitment methods and results. Ann Epidemiol 2003; 13: S18-77.
5. Yancey A, Ortega AN, Kumanyika SK. Effective recruitment and retention of minority research participants. Ann Rev Public Health 2006; 27: 1-28.
6. Bruner SW, Jones M, Buchanan D, Russo J. Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy. J Clin Oncol 2006; 24: 2209-15. (Pubitemid 46630694)
7. Gren L, Broski K, Childs J, et al. Recruitment methods employed in the prostate, lung, colorectal, and ovarian cancer screening trial. Clin Trials 2009; 6: 52-59.
8. Murphy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: face-, sex-, and age-based disparities. JAMA 2004; 291: 2720-26. (Pubitemid 38725421)
9. Cook ED, Moody-Thomas S, Anderson KB, et al. Minority recruitment to the Selenium and Vitamin E, Cancer Prevention trial (SELECT). Clin Trials 2005; 2: 436-42.
10. US Department of Commerce CB. Tobacco-use supplement to the current population survey. Available at: http://www.census.gov/cps (accessed January 2002).
11. Paskett ED, Reeves KW, McLaughlin JM, et al. Recruitment of minority and underserved populations in the United States: the centers for population health and health disparities experience. Contemp Clin Trials 2008; 29: 847-61.